Skip to content

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2004-002470-31-ES
Enrollment
Unknown
Registered
2012-04-27
Start date
2004-10-21
Completion date
Unknown
Last updated
2012-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: Lisinopril Product Name: Lisinopril / Irbesartán Product Code: A: Lisinopril / B: Irbesartán Pharmaceutical Form: Pill INN or Proposed INN: LISINOPRIL CAS Number: 83915-83-7 Current Sponso

Sponsors

Hospital Universitario Gregorio Marañón
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 1 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 1

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):

Countries

Spain

Contacts

Public ContactUnidad de Nefrología

Fundación Hospital Alcorcón

gmfernandez@fhalcorcon.es34916219500

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 15, 2026